Summary of Significant Accounting Policies (Long-term Debt) (Details)	6 Months Ended			6 Months Ended
	Jun. 30, 2014 USD ($)	Jun. 30, 2014 CAD	Dec. 31, 2013 USD ($)	Jun. 30, 2014 Term Loan due April 2013 [Member] USD ($)	Jun. 30, 2014 Term Loan [Member] Term Loan due Feb 2022 [Member] CAD	Jun. 30, 2014 Term Loan [Member] Term Loan due Feb 2022 [Member] USD ($)	Jun. 30, 2014 Term Loan [Member] Term Loan due April 2013 [Member] USD ($)
Debt Instrument [Line Items]
Period to supply pharmaceutical product	10 years	10 years
Estimated facility construction cost		14,800,000
Funded long-term debt						11,519,000	3,363,000
Less: Current Portion	1,701,000		1,665,000			1,249,000	452,000
Funded long-term debt, less current portion	13,181,000		13,998,000			10,270,000	2,911,000
Interest rate						4.00%	2.85%
Installments				$ 48,170	450,743